51 related articles for article (PubMed ID: 25341355)
1. [Pathological characteristics and prognosis of 664 patients with epithelial ovarian cancer: a retrospective analysis].
Hou MM; Chen Y; Wu YK; Xi MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):859-62, 875. PubMed ID: 25341355
[TBL] [Abstract][Full Text] [Related]
2. Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer.
Arab M; Jamdar F; Sadat Hosseini M; Ghodssi- Ghasemabadi R; Farzaneh F; Ashrafganjoei T
Asian Pac J Cancer Prev; 2018 May; 19(5):1319-1324. PubMed ID: 29802693
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
[TBL] [Abstract][Full Text] [Related]
4. Factors that contribute to the recurrence of mucinous ovarian cancer: Monocenter retrospective evaluation.
Birge O; Bakır MS; Karadag C; Doğan S; Tuncer HA; Simsek T
J Cancer Res Ther; 2023; 19(3):610-616. PubMed ID: 37470583
[TBL] [Abstract][Full Text] [Related]
5. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort.
Fortner RT; Ose J; Merritt MA; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Benetou V; Lagiou P; Agnoli C; Mattiello A; Masala G; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Weiderpass E; Torhild Gram I; Duell EJ; Larrañaga N; Ardanaz E; Sánchez MJ; Chirlaque MD; Brändstedt J; Idahl A; Lundin E; Khaw KT; Wareham N; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Sep; 137(5):1196-208. PubMed ID: 25656413
[TBL] [Abstract][Full Text] [Related]
6. Real-world study of lymphadenectomy in patients with advanced epithelial ovarian cancer.
Yin Z; Wang M
J Obstet Gynaecol Res; 2024 Apr; 50(4):663-670. PubMed ID: 38332458
[TBL] [Abstract][Full Text] [Related]
7. Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.
Ose J; Schock H; Poole EM; Lehtinen M; Visvanathan K; Helzlsouer K; Buring JE; Lee IM; Tjønneland A; Boutron-Ruault MC; Trichopoulou A; Mattiello A; Onland-Moret NC; Weiderpass E; Sánchez MJ; Idahl A; Travis RC; Rinaldi S; Merritt MA; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT
Cancer Causes Control; 2017 May; 28(5):429-435. PubMed ID: 28205047
[TBL] [Abstract][Full Text] [Related]
8. Correlation between plasma PSGL-1 and FIGO stage, tumor metastasis, and survival in epithelial ovarian cancer.
Li W; Fang C; Gao Y; Gao Y; Yan F; Chen B; Xu M
Biotechnol Appl Biochem; 2024 Mar; ():. PubMed ID: 38494670
[TBL] [Abstract][Full Text] [Related]
9. Histological Characteristics and Early-Stage Diagnosis Are Associated With Better Survival in Young Patients With Epithelial Ovarian Cancer: A Retrospective Analysis Based on Surveillance Epidemiology and End Results Database.
Huang Y; Ming X; Li B; Li Z
Front Oncol; 2020; 10():595789. PubMed ID: 33425749
[TBL] [Abstract][Full Text] [Related]
10. Epithelial ovarian cancer in younger age versus older age groups: Survival and clinicopathological features.
Kongkamsuan W; Boonyapipat S
J Cancer Res Ther; 2024 Jan; 20(1):363-368. PubMed ID: 38554347
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes.
Beaufort CM; Helmijr JC; Piskorz AM; Hoogstraat M; Ruigrok-Ritstier K; Besselink N; Murtaza M; van IJcken WF; Heine AA; Smid M; Koudijs MJ; Brenton JD; Berns EM; Helleman J
PLoS One; 2014; 9(9):e103988. PubMed ID: 25230021
[TBL] [Abstract][Full Text] [Related]
12. Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort.
Obón-Santacana M; Peeters PH; Freisling H; Dossus L; Clavel-Chapelon F; Baglietto L; Schock H; Fortner RT; Boeing H; Tjønneland A; Olsen A; Overvad K; Menéndez V; Sanchez MJ; Larrañaga N; Huerta Castaño JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Merritt MA; Trichopoulou A; Trichopoulos D; Orfanos P; Masala G; Sieri S; Tumino R; Vineis P; Mattiello A; Bueno-de-Mesquita HB; Onland-Moret NC; Wirfält E; Stocks T; Idahl A; Lundin E; Skeie G; Gram IT; Weiderpass E; Riboli E; Duell EJ
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):291-7. PubMed ID: 25300475
[TBL] [Abstract][Full Text] [Related]
13. Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.
Ose J; Poole EM; Schock H; Lehtinen M; Arslan AA; Zeleniuch-Jacquotte A; Visvanathan K; Helzlsouer K; Buring JE; Lee IM; Tjønneland A; Dossus L; Trichopoulou A; Masala G; Onland-Moret NC; Weiderpass E; Duell EJ; Idahl A; Travis RC; Rinaldi S; Merritt MA; Trabert B; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT
Cancer Res; 2017 Jul; 77(14):3951-3960. PubMed ID: 28381542
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors Influencing Survival in Ovarian Cancer Patients: A 10-Year Retrospective Study.
Andreou M; Kyprianidou M; Cortas C; Polycarpou I; Papamichael D; Kountourakis P; Giannakou K
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136256
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the prognostic value of lymphadenectomy for low-grade serous ovarian cancer: A case-control multicenter retrospective study.
Chen Z; Chu R; Shen Y; Yao Q; Chen J; Qin T; Li L; Chen G; Gao Q; Sun C; Song L; Li J; Liu P; Pan X; Li J; Zhu X; Zhang L; Qiao X; Ma D; Kong B; Song K
Transl Oncol; 2022 Sep; 23():101476. PubMed ID: 35797933
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory state of lymphatic vessels and miRNA profiles associated with relapse in ovarian cancer patients.
Johnson SC; Chakraborty S; Drosou A; Cunnea P; Tzovaras D; Nixon K; Zawieja DC; Muthuchamy M; Fotopoulou C; Moore JE
PLoS One; 2020; 15(7):e0230092. PubMed ID: 32716937
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of INPP4B is Associated with Poor Prognosis in Epithelial Ovarian Carcinoma.
Jiang L; Wang J
Int J Gen Med; 2024; 17():1059-1072. PubMed ID: 38525069
[TBL] [Abstract][Full Text] [Related]
18. Hypodontia phenotype in patients with epithelial ovarian cancer.
Fekonja A; Cretnik A; Zerdoner D; Takac I
Radiol Oncol; 2015 Mar; 49(1):65-70. PubMed ID: 25810703
[TBL] [Abstract][Full Text] [Related]
19. Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study.
Cabasag CJ; Arnold M; Rutherford M; Ferlay J; Bardot A; Morgan E; Butler J; O'Connell DL; Nelson G; Høgdall C; Schnack T; Gavin A; Elwood M; Hanna L; Gourley C; De P; Saint-Jacques N; Mørch LS; Woods RR; Altman AD; Sykes P; Cohen PA; McNally O; Møller B; Walsh P; Morrison DS; Bray F; Soerjomataram I
Int J Cancer; 2023 May; 152(9):1763-1777. PubMed ID: 36533660
[TBL] [Abstract][Full Text] [Related]
20. Impact of Sepsis on the Oncologic Outcomes of Advanced Epithelial Ovarian Cancer Patients: A Multicenter Observational Study.
Said SA; de Hullu JA; van der Aa MA; Walraven JEW; Bekkers RLM; Slangen BFM; Pickkers P; van Altena AM
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
